Skip to content

Dexketoprofen Dosage According to Chronotherapy

Efficacy of Dexketoprofen Prescribed According to the Circadian Rhythms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05176158
Enrollment
10
Registered
2022-01-04
Start date
2024-11-01
Completion date
2024-11-01
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response, Pain, Tooth, Impacted, Trismus

Keywords

Third, Dexketroprofen, Randomized

Brief summary

Lower third molar extraction is one of the most common treatments in oral surgery practice. It is a treatment with inherent complications such as postoperative pain, swelling or trismus. In order to minimize disconfort after extraction, analgesic and anti-inflammatory medication is prescribed. Recently, it is seen that circadian rhythm may play an important role on drugs metabolism, modulating its effect depending on the moment of administration. The aim of the study is to analyze if dosage modification of a Non Steroideal Anti-Inflammatory (dexketoprofen) affects on postoperative pain, swelling and open mouth limitation according the circadian clock

Detailed description

A randomized crossover split-mouth clinical trial will be performed. After third molar extractions, patients will be prescribed randomly in one side intake morning medication dosage while the contralateral side will be prescribed a night dosage. Moreover, a blood sample will be obtained to analyze the inflammatory profile.

Interventions

Pill at morning

Sponsors

McGill University
CollaboratorOTHER
Universidad Complutense de Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Bilateral impacted lower third molar

Exclusion criteria

* NSAID allergic * Contraindication of surgery

Design outcomes

Primary

MeasureTime frameDescription
Post operatory painFrom the day of the surgical procedure to the seventh-dayPostoperatory pain with Visual Analogue Scale (VAS: 0 (no pain) to 10 (worst pain))

Secondary

MeasureTime frameDescription
SwellingBaseline and post operatory (day 1, day 3, day 7)Distance from tragus to pogonion

Other

MeasureTime frameDescription
TrismusBaseline and post operatory (day 1, day 3 and day 7)Open mouth limitation in milimiters, interincisal distance
Inflammatory profile for IL-1B, IL-6, IL-8, IL-10, TNF alphaBaseline, day 3 and day 7Blood sample analysis for inflammatory cytokines in IU/ml by ELISA test (enzyme-linked immunoassay)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026